RENALYTIX PLC
AI diagnostics platform assessing kidney disease progression risk in diabetic patients.
RENX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYWL4Y04 (+1 more)
- LEI:
- 213800NTOH3FK3WER551
- Country:
- United Kingdom
- Address:
- 2 LEMAN STREET, E1W 9US LONDON
- Website:
- https://renalytix.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on optimizing the clinical management of kidney disease. The company develops bioprognostic solutions to assess the risk of disease progression. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized testing platform that provides a risk score for the progressive decline of kidney function in adults with type 2 diabetes and early-stage chronic kidney disease (CKD). By enabling early risk identification, the platform helps clinicians and healthcare systems target resources and guideline-recommended treatments to improve patient outcomes and slow disease advancement. The company partners with health systems, insurers, and pharmaceutical companies to implement its technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-10 15:34 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.5 KB | ||
| 2025-10-10 08:01 |
Major Shareholding Notification
Holding(s) in Company
|
English | 185.3 KB | ||
| 2025-10-10 08:00 |
Regulatory News Service
$4m balance sheet improvement with bond conversion
|
English | 18.6 KB | ||
| 2025-10-09 17:43 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.5 KB | ||
| 2025-10-07 16:03 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB | ||
| 2025-10-03 15:32 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.5 KB | ||
| 2025-10-02 15:57 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB | ||
| 2025-10-01 15:43 |
Major Shareholding Notification
Holding(s) in Company
|
English | 41.0 KB | ||
| 2025-10-01 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 41.2 KB | ||
| 2025-10-01 08:00 |
Regulatory News Service
CE Mark application submission
|
English | 17.7 KB | ||
| 2025-09-30 17:02 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.5 KB | ||
| 2025-09-29 15:28 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.7 KB | ||
| 2025-09-29 10:32 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB | ||
| 2025-09-29 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.7 KB | ||
| 2025-09-24 15:00 |
Earnings Release
Update Regarding Forward Guidance
|
English | 15.7 KB |
Automate Your Workflow. Get a real-time feed of all RENALYTIX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for RENALYTIX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
